Search by Drug Name or NDC
NDC 68462-0135-08 abiraterone acetate 250 mg/1 Details
abiraterone acetate 250 mg/1
abiraterone acetate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Glenmark Pharmaceuticals Inc., USA. The primary component is ABIRATERONE ACETATE.
MedlinePlus Drug Summary
Abiraterone is used in combination with prednisone to treat a certain type of prostate cancer that has spread to other parts of the body. Abiraterone is in a class of medications called androgen biosynthesis inhibitors. It works by decreasing the amount of certain hormones in the body.
Related Packages: 68462-0135-08Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Abiraterone
Product Information
| NDC | 68462-0135 |
|---|---|
| Product ID | 68462-135_55e39d73-7edc-4719-9343-db296e0609cb |
| Associated GPIs | 21406010200320 |
| GCN Sequence Number | 067349 |
| GCN Sequence Number Description | abiraterone acetate TABLET 250 MG ORAL |
| HIC3 | V1J |
| HIC3 Description | ANTINEOPLASTIC - ANTIANDROGENIC AGENTS |
| GCN | 29886 |
| HICL Sequence Number | 037571 |
| HICL Sequence Number Description | ABIRATERONE ACETATE |
| Brand/Generic | Generic |
| Proprietary Name | abiraterone acetate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | abiraterone acetate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 250 |
| Active Ingredient Units | mg/1 |
| Substance Name | ABIRATERONE ACETATE |
| Labeler Name | Glenmark Pharmaceuticals Inc., USA |
| Pharmaceutical Class | Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA209227 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 68462-0135-08 (68462013508)
| NDC Package Code | 68462-135-08 |
|---|---|
| Billing NDC | 68462013508 |
| Package | 120 TABLET in 1 BOTTLE (68462-135-08) |
| Marketing Start Date | 2019-10-16 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.89948 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | ABIRATERONE ACETATE 250 MG TAB |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis